A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals

Published:2020-08-04 Issue:5 Volume:324 Page:455
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Casadevall Arturo¹,Joyner Michael J.²,Pirofski Liise-Anne³

Affiliation:

1. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota

3. Montefiore Medical Center, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2766940/jama_casadevall_2020_ed_200053.pdf

Reference14 articles.

1. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?;Luke;Ann Intern Med,2006

2. Use of convalescent plasma therapy in SARS patients in Hong Kong.;Cheng;Eur J Clin Microbiol Infect Dis,2005

3. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.;Hung;Clin Infect Dis,2011

4. Effectiveness of convalescent plasma therapy in severe COVID-19 patients.;Duan;Proc Natl Acad Sci U S A,2020

5. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma.;Shen;JAMA,2020

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies;The EMBO Journal;2024-02-28

2. Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID;MedComm;2023-11-15

3. Exercise and Experiments of Nature;Comprehensive Physiology;2023-06-26

4. Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2;2023-05-30

5. Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence;Children;2023-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3